Serum Institute

Serum Institute Writes To PMO, Proposes Reforms In Drug Regulatory System

India News | Press Trust of India | Friday March 5, 2021

The world's largest vaccine manufacturer by volume, Serum Institute of India, has written to the Prime Minister's Office proposing reforms in the existing drug regulatory system, including allowing manufacturing and stockpiling of non-COVID vaccines while undergoing clinical trial.

Explain Strict Control Over Who Can Be Vaccinated: High Court To Centre

India News | Press Trust of India | Thursday March 4, 2021

The Delhi High Court Thursday asked the Centre to explain the rationale behind keeping strict control over class of persons who can be vaccinated against COVID-19 currently as under the present system those above the age of 60 years or with comorbidities can receive vaccination.

UK To Receive 10 Million AstraZeneca Covid Vaccine Doses From India: Report

India News | Reuters | Wednesday March 3, 2021

The UK will receive 10 million AstraZeneca COVID-19 vaccine doses made by the Serum Institute of India (SII), the UK government said in a statement on Tuesday.

"Proud To Take The Jab": What Natasha Poonawalla Said On Serum Institute's Covishield

India News | Reported by Sukirti Dwivedi, Edited by Shylaja Varma | Tuesday March 2, 2021

Natasha Poonawalla, Serum Institute of India's Executive Director, was today vaccinated against COVID-19. She received the first shot of Covishield which is manufactured by her company and developed by AstraZeneca and Oxford University.

COVID-19 Vaccine Makers Serum Institute of India, Bharat Biotech Targeted by Chinese Hackers: Cyfirma

Reuters | Monday March 1, 2021

Indian COVID-19 vaccine makers Serum Institute of India (SII) and Bharat Biotech have been targeted by a Chinese state-backed hacking group, cyber intelligence firm Cyfirma has said. COVID-19 vaccines produced by the two companies are being used in the country's immunisation campaign.

Chinese Hackers Target India’s Serum Institute, Bharat Biotech: Report

India News | Reuters | Monday March 1, 2021

A Chinese state-backed hacking group has in recent weeks targeted the IT systems of two Indian vaccine makers whose coronavirus shots are being used in the country's immunisation campaign, cyber intelligence firm Cyfirma told Reuters.

How India Is Beating China At Its Own Game In Vaccine Diplomacy

India News | Iain Marlow, Archana Chaudhary, Kari Lindberg, Bloomberg | Friday February 26, 2021

India's huge capacity to make coronavirus vaccines is helping the country take on China in the battle to gain political influence across the developing world.

AstraZeneca, Novavax Ready To Scale Up COVID-19 Vaccine Production In Tie-Up With Serum Institute

India News | Press Trust of India | Thursday February 25, 2021

British-Swedish pharma giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.

Serum Institute Despatches 1st Batch Of Vaccine Shots For Covax Scheme

India News | Agence France-Presse | Tuesday February 23, 2021

India's Serum Institute, the world's largest vaccine manufacturer, despatched on Tuesday its first batch of vaccine shots for the Covax global inoculation programme.

Nepal Gets 1 Million Doses Of COVID-19 Vaccine Bought From India

India News | Press Trust of India | Sunday February 21, 2021

Nepal on Sunday received the one million doses of Covishield vaccine it bought from India's Serum Institute, in a major boost to the country's fight against the COVID-19 pandemic.

"Please Be Patient": Adar Poonawalla To Nations Waiting For Vaccines

India News | Reported by Vishnu Som, Edited by Swati Bhasin | Sunday February 21, 2021

World's biggest vaccine maker Serum Institute of India's Adar Poonawalla this morning urged the nations to "be patient" amid the wait for Covishield, the coronavirus vaccine that the SII has developed in partnership with the Oxford University and British-Swedish pharma firm AstraZeneca.

On Plea To Declare Covishield "Unsafe", High Court Notice To Centre

India News | Reported by J Sam Daniel Stalin, Edited by Swati Bhasin | Saturday February 20, 2021

The Madras High Court has issued a notice to the central government over a petition to declare the Pune-based Serum Institute of India's "Covishield" unsafe.

Not True: South Africa Denies Serum Institute Asked To Take Back Vaccine Doses

World News | Reuters | Thursday February 18, 2021

South Africa plans to share 1 million AstraZeneca COVID-19 vaccine doses with other African countries, a senior official said, as the government confirmed the first shots from rival Johnson & Johnson would arrive on Tuesday evening.

South Africa Asks Serum Institute To Take Back 1 Million Vaccine Doses: Report

India News | Reuters | Wednesday February 17, 2021

South Africa has asked the Serum Institute of India to take back the one million COVID-19 vaccine doses the company had sent in early February, The Economic Times reported on Tuesday, a week after the country said it will put on hold use of AstraZeneca's shot in its vaccination program.

Will Send Covid Vaccine To Canada In "Less Than A Month": Serum Institute

India News | Reuters | Monday February 15, 2021

The Serum Institute of India will ship the Oxford University/AstraZeneca COVID-19 vaccine to Canada in less than one month, Serum's chief executive said on Monday.